Improved Detection of Neonatal Sepsis Using a Targeted Biomarker Assay

Completed

Conditions studied: Neonatal Sepsis

In brief

The purpose of this study is to determine whether analysis of specific serum biomarkers will improve the diagnosis of late onset neonatal sepsis and to determine the correlation between plasma levels of specific cytokines and bacteremia in NICU patients \>3 days of age.

Key facts

Study ID

NCT01120678

Run by

University of Virginia

People needed

250

Starts

2009-02-01

Expected to finish

2010-07-01

Last updated by the study team

2020-11-04

Who can join

Age: 0 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• NICU patients > 3 days of age

You may not qualify if…

• less than 3 days old or no waste blood available

Where it is running

• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States
• University of Virginia Neonatal Intensive Care Unit — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.